European Healthtech startup funding raised during Q1 2015.
In Q1 2015, 37 European Healthtech companies raised a combined €247M across 39 funding rounds, up 1.0% versus Q1 2014. Switzerland led by capital raised, and Imprimatur Capital was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| CRISPR Therapeutics | Series B | Mar 2015 | €59M |
| CureVac | Series D+ | Feb 2015 | €46M |
| Echosens | Growth/Late | Mar 2015 | €31M |
| Allecra Therapeutics | Series A |
7 exits · €273M disclosed.
| Dezima Pharma | Acquisition | Feb 2015 | €273M |
| Mar 2015 |
| €15M |
| BONESUPPORT | Growth/Late | Mar 2015 | €13M |
| Onbone | Early VC | Mar 2015 | €10M |
| Vittamed | Other | Mar 2015 | €9.3M |
| MindMaze | Seed | Feb 2015 | €7.7M |
| Zebra Medical Vision | Seed | Mar 2015 | €7.3M |
| Philips Interoperability Solutions | Series A | Mar 2015 | €5.0M |
| Rigontec | Series A | Feb 2015 | €4.8M |
| EarlySense | Series D+ | Mar 2015 | €4.6M |
| TrialBee | Series A | Feb 2015 | €4.5M |
| Zembro | Seed | Mar 2015 | €4.5M |
| MySugr | Series A | Feb 2015 | €4.3M |
